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Abstract
Hemiparkinsonism-hemiatrophy (HPHA) is a rare neuro-
logical syndrome. The main clinical features of HPHA con-
sist of atrophy of one side of the body (face, trunk, limbs),
ipsilateral hemiparkinsonism (bradykinesia, rigidity, tremor)
and in many cases dystonia. There are no data on prevalence
of HPHA as the condition is rare. The mean age of parkin-
sonism onset is earlier than in idiopathic Parkinson disease
(43.7 years, range: 15-63). Changes in magnetic resonance
imaging (MRI) (cortical, basal ganglia atrophy contralater-
ally to the side of clinical presentation) are described in 30%
of patients. The pathogenesis of HPHA is unknown, but in
many cases a history of prenatal injuries was reported.
We present two male patients with HPHA – 45 and 55 years
old, with left-sided parkinsonism, dystonia and hemiatrophy
(to our knowledge, the first Polish cases). Both patients had
no atrophic changes in MRI and levodopa treatment was inef-
fective. In the discussion the authors review current litera-
ture on HPHA.
Key words: hemiparkinsonism, hemiatrophy, parkinsonism,
dystonia, head injury.
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CASE REPORT/OPIS PRZYPADKU
St reszc zen ie
Zespó³ hemiparkinsonizm-hemiatrofia (hemiparkinsonism-hemi-
 atrophy – HPHA) jest rzadkim schorzeniem neurologicznym.
G³ównymi objawami s¹ zanik po³owy cia³a (w zakresie twarzy,
tu³owia, koñczyn) oraz to¿stronny zespó³ parkinsonowski (bra-
dykinezja, sztywnoœæ, dr¿enie), któremu u wielu chorych towa-
rzyszy tak¿e dystonia. Z powodu rzadkiego wystêpowania tego
schorzenia nie ma danych epidemiologicznych. Œrednia wieku
pojawienia siê objawów parkinsonowskich jest ni¿sza ni¿ dla
idiopatycznej choroby Parkinsona i wynosi 43,7 roku (zakres:
od 15 do 63 lat). Zmiany w badaniu obrazowym mózgu (po -
³owiczy przeciwstronny zanik korowy i podkorowy) opisywa-
ne s¹ w 30% przypadków. Patogeneza choroby jest nieznana,
ale w wielu przypadkach opisywano zaburzenia w okresie pre-
natalnym.
W pracy prezentujemy dwóch pacjentów z HPHA – mê¿ -
czyzn w wieku 45 i 55 lat z objawami lewostronnego parkin-
sonizmu, dystonii i po³owiczego zaniku cia³a. U ¿adnego z pa -
cjentów nie stwierdzono zmian w badaniu za pomoc¹ rezonansu
magnetycznego. OdpowiedŸ na lewodopê by³a ograniczona.
Wed³ug naszej wiedzy jest to pierwsza polska publikacja pre-
zentuj¹ca HPHA. W dyskusji dokonano tak¿e przegl¹du
piœmiennictwa na ten temat.
S³owa kluczowe: po³owiczy parkinsonizm, po³owiczy zanik,
parkinsonizm, dystonia, uraz g³owy.
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Introduction
Hemiparkinsonism-hemiatrophy (HPHA), first des -
cribed by Klawans in 1981 [1], is a rare neurological syn-
drome. The main clinical features of HPHA consist of
atrophy of one body side (in a majority of cases observed
since early childhood) and ipsilateral hemiparkinsonism,
which usually appears later [2,3]. The hemiatrophy of
one or more parts of the body (face, upper and lower limb,
trunk) is observed with similar predilection for the left 
or right side. Magnetic resonance imaging (MRI) may
show contralateral or ipsilateral atrophy of the cortex and
the basal ganglia in inconsistent forms (i.e. focal or dif-
fuse atrophy). However, MRI changes are described 
in only 30% of HPHA patients [2,3]. 
The progression of parkinsonian symptoms (such as
bradykinesia, rigidity and tremor) is relatively slow.
Accompanying dystonic movements are observed in 70%
of cases and were reported as the first HPHA symptom
in 50% of patients [2]. In some HPHA studies, the
presence of pyramidal signs (brisk tendon reflexes and
Babinski sign) has been consistently noted [2,4].
The mean age of parkinsonism onset is 43.7 years,
but it ranges from 15 to 63 years [2]. There are no data
on prevalence of HPHA as the condition is rare and the
largest observed group from the referral movement dis-
orders centre consisted of 30 patients [2]. 
Levodopa response is variable – in 60% of cases it
is noted as good; in 20% moderate; and in 20% low or
no response was observed [2,4]. 
The pathogenesis of HPHA is unknown. However,
in many cases a history of prenatal injuries was report-
ed [1-3]. Recently, parkin mutations were found in one
case [5].
The literature on HPHA is scarce and to our knowl-
edge this unusual syndrome has never been reported in
Polish patients. 
Case reports
Case 1 was a 45-year-old, right-handed male patient
without family history of parkinsonism or dystonia. 
The patient denied having any prenatal or birth-related
problems or severe infections in early childhood. Age at
the onset of parkinsonism was 34 and the first noticed
symptom was left upper limb rest tremor. One year lat-
er the symptoms of bradykinesia within left extremities
were observed. Subsequently, 3 years later, after one
month of levodopa administration (which was not effec-
tive), he developed cervical dystonia (spasmodic torticol -
lis to the left side) with subsequent progression. Levo -
dopa was discontinued and botulinum toxin type A
treatment was started with a good response.
The clinical presentation (at the fifth year after onset)
was characterized by asymmetric, left-sided parkinson-
ism, multifocal dystonia (torticollis with head rotated to
the left, jaw-opening dystonia and dystonia of the left
foot) and left-sided hyperreflexia. Features of ipsilateral
hemiatrophy included shortening of the left lower limb
(length of the right lower limb was 84 cm, and length of
the left lower limb was 81 cm); difference in thigh cir-
cumferences (right: 40 cm, left: 38 cm); left hand small-
er than right hand (Fig. 1); and feet asymmetry (Fig. 2).
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Fig. 1. Case 1. Left hand atrophy
Fig. 2. Case 1. Left foot atrophy
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MRI scans showed decreased signal within the glo -
bus pallidus bilaterally on T1- and T2-weighted images
(Fig. 3) and regional cerebral blood flow (rCBF) assess -
ed with single photon emission computed tomo graphy
(SPECT) using 99mTc-HMPAO showed normal brain
perfusion. Mini-Mental State Examination (MMSE)
showed no cognitive impairment (30 points). Progres-
sion of the disorder was observed at 5.5 years follow-
up: Unified Parkinson’s Disease Rating Scale (UPDRS)
total score (I-IV) increased from 42 to 70, Hoehn-Yahr
score from 2.5 to 3.0 and Schwab-England score de -
creased from 80% to 70%. Pharmacological treatment
(levodopa, piribedil, ropinirole) was ineffective. Moder-
ate improvement was observed only with biperiden.
Case 2 was a 55-year-old, right-handed male patient,
without family history and without any prenatal or birth-
related injuries or severe infections in early childhood.
He reported a history of sensorineural hearing loss since
childhood. The onset of parkinsonism was reported 
at the age of 49 and during the following two years rigid-
ity of the left upper and lower limb (preceded by left
shoulder pain) developed and after 5 years asymmetric
bradykinesia of left extremities and gait disturbances
(shuffling gait) occurred. At the time of the last exami-
nation (at the sixth year from onset), he presented hypo -
mimia, asymmetric left-sided parkinsonism with rigid-
ity, left-sided hyperreflexia and dystonic posturing of the
left hand. Moreover, the following features of left-sided
hemiatrophy were observed: mild hemifacial asymme-
try and weakness; difference in thigh circumference
(right thigh: 43 cm, left thigh: 40 cm); dorsal muscles
atrophy (Fig. 4); left hand smaller than right one (Fig. 5);
and feet asymmetry (Fig. 6).
MRI scans showed mild cortical atrophy of frontal
lobes, and bilateral small white matter hyperintensities
(Fig. 7). In rCBF SPECT with 99mTc-HMPAO,
global hypoperfusion was found without significant
asymmetry. Complex neuropsychological assessment
showed low mood (Beck Depression Inventory score
was 18), language, executive function, visual memory
and dynamic praxis impairment (assessed with: Boston
Naming Test, Halstead-Reitan Category Test, Tower of
London 2, CFT Rey, and Luria praxis performance).
Verbal memory, short-term memory and operative mem-
ory were not impaired. MMSE score was 27. 
The levodopa response was poor (UPDRS motor
score part III on-medication: 18, off-medication: 19),
Fig. 3. Case 1. MRI scan shows hypointensities within the globus pallidus on
both T1- and T2-weighted images
Fig. 4. Case 2. Dorsal muscles asymmetry – left side atrophy Fig. 5. Case 2. Left hand atrophy
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but the patient reported subjective improvement on
treatment. 
Discussion
Hemiparkinsonism-hemiatrophy is a very rare (or
unrecognized) neurological syndrome and to date only
68 cases have been reported in the literature (only single
case reports or case series). The widest presentation of
HPHA was published in 2007 by Wijemanne and Jan -
kovic, who analysed the clinical spectrum of 30 patients
who fulfilled the diagnostic criteria [2]. Buchman et al.
[6] studied 15 patients with HPHA, presenting slow
progression of the disorder and introducing clinical cri-
teria for hemiatrophy and hemiparkinsonism. Giladi 
et al. [7] presented clinical and radiological correlates of
11 HPHA patients with or without brain atrophy. 
The clinical presentation of case reports and case series
reported to date along with two reported Polish patients
is presented in Table 1.
Parkinsonian symptoms in HPHA usually develop
at an early age. The range of age at onset was from 15
to 63, but mean age of onset was 43.7 [2]. Left and
right sides were equally represented [2,4]. The clinical
spectrum varies from bradykinesia and rigidity (in some
studies observed in all patients [2], in one study only in
19% [4]), to tremor (40% of patients [2] and 56% [4]),
dystonia (70% [2] and 22%[4]) and also gait [4] or
eye-movement abnormalities [8], falls [2], and freez-
ing [2], especially asymmetric freezing of the affected
side of the body [9]. Most HPHA patients developed
a wide range of dystonia presentations: focal dystonia
(e.g. leg or hand posturing dystonia), multifocal,
hemidystonia, action-induced and early morning dysto-
nia [2], as was observed in our Case 1 as well. In 50%
of HPHA patients [2] dystonia was noticed as the first
symptom. Some patients had pyramidal signs: brisk ten-
don reflexes on the atrophic side or bilateral, but Babin-
ski and Hoffman signs were noted only in a few cases
[4]. The pyramidal signs suggests that atrophy and brain
tissue injury in HPHA can involve not only extrapyra-
midal, but also pyramidal tracts [2].
In a majority of cases, atrophy of one body side was
observed since early childhood and symptoms of parkin-
sonism occurred many years later, but there were report-
ed patients with hemiatrophy diagnosed along with
parkinsonism at the same time. 
Morphological abnormalities in HPHA include not
only atrophy, but also skeletal deformities (scoliosis and
joint deformities) [2]. Atrophy was observed within the
face, hands, legs and trunk. The more frequently in -
volved areas were the upper limbs, followed by lower
limbs and face, but one area of the body may be more
affected by atrophy than the rest of the body on the same
side [2]. The severity of atrophy varied from mild to
severe [2,13]. Wijemanne and Jankovic suggest that
hemiatrophy is the result of failure in patients’ develop-
ment, and not a later-life occurring phenomenon. Most
of their patients manifested atrophy and had problems
such as difficulties in correctly fitting shoes in their ear-
ly life [2].
The MRI findings in patients with HPHA can be
grouped into the following categories: focal atrophy or
diffuse cerebral hemiatrophy; single or multiple focal
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Fig. 7. Case 2. MRI scan shows mild cortical atrophy of frontal lobes, and bila-
teral small size white matter hyperintensities
Fig. 6. Case 2. Left foot atrophy
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lesions in the basal ganglia; single or multiple focal lesions
outside the basal ganglia; and normal scans [2]. Abnor-
malities were found in 30% of HPHA patients, but in
most cases MRI scans were normal [2,4,10]. No corre-
lations between clinical presentation, history of prenatal
or birth-related head injury and MRI brain atrophy were
found [2,10]. In MRI diffusion tensor imaging (DTI),
low values of fractional anisotropy (FA) were found in
both putaminal regions, which may suggest a possible
lack of integrity within the myelin fibres. The evidence 
of lower values of FA also in the subthalamic nucleus sug-
gests the involvement of these parts of the brain, where
glutamatergic transmission is present. The evidence of
normal FA and mean diffusivity (MD) values in all the
nigral regions seems to rule out a major role of dopamin-
ergic neurons in the pathogenesis of HPHA [11].
Positron emission tomography (PET) with [18F]-
flu orodeoxyglucose (FDG) showed decreased glucose
metabolism in caudate and lentiform nuclei or the frontal
cortex, contralateral to the side of the body affected.
[18F]-fluorodopa (FDP) PET scans have shown re duc -
ed uptake in the contralateral striatum in some HPHA
patients; however, bilateral reduction in FDP uptake
and no reduced uptake were also reported. [3] 
The pathogenesis of HPHA is still unknown, but 
the wide range of clinical features, neuroimaging and 
functional tests suggests that the aetiology may be hete -
rogeneous. Klawans, who first described the HPHA 
syndrome in 1981, presented four male patients with evi-
dence of hemiatrophy (due to early-life hemispheric injury)
who developed hemiparkinsonism [1]. Wijemanne and
Jankovic [2] reported that 47% of described patients 
suffered from prenatal, birth-related or neonatal injuries,
febrile infection or major injury in childhood. There was
no defined pathomechanism of injury or localization res -
ponsible for HPHA symptoms. In one study parkin muta-
tions in one examined patient were found – the clinical
spectrum was similar to other HPHA studies. The com-
plementary metabolic and receptor pattern of PET lig-
ands corresponded to that typically found in idiopathic
Parkinson disease (PD), although tracer binding asym-
metry was lacking [5]. As hemiatrophy is an early and
non-progressive symptom, parkinsonism progresses over
time, although it is not rapid as in idiopathic Parkinson
disease. The cause of this progression remains unknown.
One may speculate that it is age-related neuronal loss com-
bined with an initially injured (e.g. perinatally) dopamin-
ergic system, but the lesions are probably more widespread
as a significant proportion of patients do not respond to
levodopa and present with different forms of dystonia and
pyramidal symptoms. To our knowledge there are no pub-
lished postmortem data on HPHA.
Number Age of onset Dystonia (%) Response Abnormal birth
of patients (mean, range) to treatment (%) history (%)
Klawans, 1981 [1] 4 40.0 0% 0% 100%
Buchman et al., 1988 [6] 1 43.7 (31-61) 67% 78% 50%
5
Giladi et al., 1990 [7] 1 38.1 (18-54) 27% 70% 0
1
Przedborski et al., 1994 [12] 6 49 (23-59) 83% 33% 0
Lang, 1995 [14] 1 27 present good present
Martinelli et al., 1998 [4] 1 55 absent good absent
Marchioni et al., 1999 [8] 1 45 absent poor absent
Jenkins et al., 2002 [15] 1 19 present not tried absent
Pramstaller et al., 2002 [5] 1 29 present good absent
Wijemanne & Jankovic, 2007 [2] 3 44.2 (15-63) 70% 80% 47%
0
Tessitore et al., 2010 [3] 1 50 present good absent
Dziadkiewicz et al. 2 34 present poor absent
49 absent poor absent
Table 1. The clinical spectrum of reported case series with hemiparkinsonism-hemiatrophy syndrome
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The levodopa response in HPHA patients is vari-
able. A poor levodopa response was reported by Klawans
[1], but in the majority of cases, good or moderate results
were observed [13], which is not in concordance with
the findings of Pisani et al. suggesting that dopaminer-
gic neurons are not involved in HPHA pathogenesis [2,
11]. Levodopa-induced fluctuations and dyskinesias
were rarely reported, which may suggest that presynap-
tic nigro-striatal degeneration is not present or very mild-
ly progressing in HPHA [2,4]. There are no studies or
data on the correlation between DaTSCAN or MRI
imaging and levodopa response in HPHA patients.
Ablative surgery and deep brain stimulation were report-
ed in some cases, but the results were inconclusive, prob-
ably due to heterogeneous underlying pa thology [2]. 
Both presented patients fulfil the main HPHA cri-
teria: asymmetric parkinsonism of early onset (before
50) and ipsilateral atrophy of one side of the body.
Parkinsonian symptoms observed in our cases consist-
ed of hypomimia, bradykinesia and rigidity with rest
tremor in Case 1 and with no tremor in Case 2. In both
cases dystonia was reported: in Case 1, severe and mul-
tifocal dystonia; in Case 2, the left hand presented dys-
tonic posturing only (elbow flexion), resembling that
typical for idiopathic Parkinson disease. Both had brisk
tendon reflexes ipsilaterally to parkinsonian symptoms.
Hemiatrophy was recognized within the face, and upper
and lower limbs. On MRI scans, no evidence of corti-
cal or basal ganglia asymmetric atrophy was found, but
in Case 1 decreased signal of the globus pallidus was
noticed. Regional cerebral blood flow SPECT was nor-
mal in Case no. 1 and global hypoperfusion (referred to
cerebellar perfusion) was reported in Case 2, but this
patient was also older. In both presented cases dopamin-
ergic treatment was ineffective. Parkinsonian syndromes
with asymmetrical presentation should be taken into
account at differential diagnosis, especially idiopathic
Parkinson disease, corticobasal syndrome (CBS) and
multiple system atrophy (MSA), but in all of them the
rate of progression is much faster and the clinical spec-
trum involves cerebellar and autonomic dysfunction
(MSA), apraxia and the alien limb phenomenon along
with myoclonus (CBS), and good responsiveness to lev-
odopa and lack of dystonia at early stages (Parkinson
disease). Patients with these types of parkinsonism are
also older than patients with HPHA.
In conclusion, HPHA should be suspected in cases
of early onset, slowly progressive, asymmetric parkin-
sonism combined with ipsilateral hemiatrophy (or con-
tralateral cerebral hemiatrophy on MRI) and focal dys-
tonia. The supportive features include poor response to
levodopa, positive history of perinatal injury and lack of
dementia. HPHA seems to be a clinical presentation
without definite pathology and possibly heterogeneous
pathogenesis.
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